Filing Details

Accession Number:
0001415889-24-005093
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-23 17:30:04
Reporting Period:
2024-02-06
Accepted Time:
2024-02-23 17:30:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1726445 Seer Inc. SEER Laboratory Analytical Instruments (3826) 821153150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834217 R. David Horn C/O Seer, Inc.
3800 Bridge Parkway, Suite 102
Redwood City CA 94065
President & Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-02-06 165,038 $0.00 493,195 No 4 A Direct
Class A Common Stock Disposition 2024-02-22 12,684 $1.58 480,511 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Acquisiton 2024-02-06 142,557 $0.00 142,557 $1.77
Class A Common Stock Employee Stock Option (right to buy) Acquisiton 2024-02-06 140,000 $0.00 140,000 $1.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
142,557 2034-02-06 No 4 A Direct
140,000 2034-02-06 No 4 A Direct
Footnotes
  1. The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025.
  2. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of RSUs.
  3. One-fourth of the shares subject to the option vest on February 6, 2025 and 1/48th of the shares vest monthly thereafter.
  4. The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 200% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments.